You are here

  • Home
  • Archive
  • Volume 4, Issue 2
  • Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study

Citation Tools

Article menu
Original research
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Pantzaris MC, Bakirtzis C, Grigoriadis N, et al
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study
BMJ Neurology Open 2022;4:e000334. doi: 10.1136/bmjno-2022-000334